Delivery Order SPE2DB20D7066-SPE2DB24FC2KK
Award Date
7/17/24
Potential Completion Date
7/18/24
Potential Value
$64K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,359,320 units of Vyvanse 50 mg capsules. The contract has a ceiling value of $4,006.50 and is a firm-fixed price delivery order, with a period of performance through November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,728,779 units of the prescription medication Vyvanse 40 mg capsules. The contract has a ceiling value of $2,675.40 and a period of performance through December 17, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4,566,110,605 units of the pharmaceutical drug Vyvanse 40 mg capsule. The contract has a total ceiling value of $4,796.63 and a completion date of October 16, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,747,920 units of the prescription medication Vyvanse 40 mg capsules. The contract is a Firm Fixed Price Delivery Order worth $2,527.50 and has an ultimate completion date of December 18, 2024. The contract was not set aside for any specific business type. AmerisourceBergen, a for-profit organization, holds multiple Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567444350 units of the medication Vyvanse 10 mg capsules. The contract has a ceiling value of $3,868.34 and is a firm fixed price delivery order with a completion date of March 4, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,337.70, is for the delivery of 4,566,554,640 capsules of the medication Vyvanse 30 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 27, 2024. The contract was awarded on November 26, 2024 and does not have a set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,886,411 units of the medication Vyvanse 60 mg capsules. The total ceiling value of the contract is $7,348.07, and it is a firm fixed price, delivery order contract type that runs through April 14, 2025. The contract does not have a set-aside designation, indicating it was...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4,565,026,683 units of the medication Vyvanse 10mg in 100-count capsules. The contract has a ceiling value of $2,586.00 and a period of performance through July 1, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999, which enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,713,994 units of Vyvanse 50 mg capsules. The contract has a ceiling value of $2,577.79 and is a firm fixed-price delivery order with a completion date of December 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...